| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| Net Income | $0.1B | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.98 | $5.58 | $5.82 | $5.57 | $4.69 | $0.91 | $0.79 | $0.76 |
| EPS (Diluted) | $3.93 | $5.52 | $5.77 | $5.52 | $4.55 | $0.91 | $0.78 | $0.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.4B | $2.4B | $2.4B | $2.4B | $2.1B | $1.8B | $0.7B | $0.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Total Liabilities | $0.5B | $0.4B | $0.4B | $0.5B | $0.5B | $0.2B | $0.2B | $0.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.8B | $1.9B | $2.0B | $2.0B | $1.6B | $1.5B | $0.5B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.0B | $-0.4B | $-0.4B | $-1.0B | $-0.3B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.2B | $-0.2B | $0.2B | $0.2B | $0.9B | $0.4B | $0.2B |